The degree of electroanatomical remodeling of the left atrial (LA) affects the clinical outcome after rhythm control of atrial fibrillation (AF). Our hypothesis was that plasma concentrations of transforming growth factor (TGF)-β and tissue inhibitor of metalloproteinase (TIMP)-1 reflect LA voltage and structural remodeling in patients with non-valvular AF.
trial fibrillation (AF), one of the most common arrhythmias in clinical practice, is related to increasingly high mortality and disability. 1 Several studies have shown that AF changes the electrophysiologic properties of atrial myocardium and causes alterations in the structure of atrial tissue. 2, 3 The longer the duration of AF is, the more persistent AF becomes because of atrial remodeling. Both electrical remodeling and structural remodeling beget AF, so that an increase in AF burden leads to a more vulnerable substrate. 4 The electrical remodeling is presented by shortened atrial refractory period and slow conduction velocity in the atrium. 2, 4 The structural remodeling is related to the interstitial fibrosis, downregulation of the density of gap junction, and enlargement of atrial chamber size (critical mass). 5, 6 While the electrical remodeling might be able to be reversed by maintaining the sinus rhythm, structural substrate remodeling might persist even after rhythm control. 7 The degree of structural remodeling measured by left atrial (LA) size 8 or multiple serologic markers 9,10 affects the clinical outcome of rhythm control in patients with AF. Therefore, non-invasive predictor of electroanatomical remodeling might be valuable to select appropriate patients with AF for rhythm control and improve their clinical outcome. Transforming growth factor (TGF)-β is central to signaling cascades implicated in the genesis of cardiac fibrosis. 11 The balancing of matrix metalloproteinase (MMP) and tissue inhibitor of
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metalloproteinase (TIMP) regulate extracellular matrix turnover. 12-14 Therefore, we hypothesized that plasma concentrations of TGF-β and TIMP-1 can be used to predict LA voltage and LA structural remodeling in patients with nonvalvular AF. The purpose of the current study was to define the association of non-invasive parameters to the degree of electroanatomical remodeling (voltage and volume) of LA.
Editorial p 536 Methods

Patient Selection
The study protocol was approved by the Institutional Review Board and adhered to the declaration of Helsinki. All patients provided written informed consent. We included 242 AF patients (male 79.4%, 55.1±11.0 years old) who underwent radiofrequency catheter ablation (RFCA) guided by computed tomography (CT) merged 3D NavX map. Among them, 87 patients had persistent AF (PeAF) and 155 had paroxysmal AF (PAF). We excluded the following patients: (1) permanent AF refractory to the electrical cardioversion; (2) LA size >55 mm measured on echocardiogram; (3) aortic aneurysm or dissection; (4) AF with rheumatic valvular disease; or (5) previous AF ablation. All patients maintained optimal anticoagulation and stopped taking all anti-arrhythmic drugs for 5 half-lives of each drug. We examined all patients with 3D spiral CT (64 Channel, Light Speed Volume CT, Philips, Brilliance 63, Netherlands) to visually define the anatomy of LA.
Electrophysiological Mapping
Intracardiac electrograms were recorded using a Prucka CardioLab™ Electrophysiology system (General Electric Health Care System Inc, Milwaukee, WI, USA). We generated 3D-spiral CT merged 3D electroanatomical mapping (NavX system, St. Jude Medical Inc, Minneapolis, MN, USA) for RFCA. Before the catheter ablation, we generated a LA 3D voltage map by obtaining contact bipolar electrograms from 250 to 350 points of the LA endocardium during high right atrial (RA) pacing (pacing cycle length 500 ms) utilizing a deflectable 3. 
Curvilinear and Volumetric Analyses of 3D-Spiral CT Image
We measured the LA volume by CT. The 3D-spiral CT images of LA were analyzed on an imaging processing workstation (Aquarius, Terarecon Inc, USA) as described before. 16 Each LA image was divided into portions by embryological origin 17 as follows: the venous LA (posterior LA including the antrum and posterior wall), anterior LA (excluding the LA appendage (LAA) and venous LA), and LAA. Although both LAA and anterior LA are embryological primordial atrial origin, they are different in geometry, myocardial fiber orientations, and distribution of autonomic innervations. 16, 18 Therefore, we separated LAA and anterior LA, and referenced them to the points of inflection on 3D spiral CT image. We calculated and compared the absolute and relative volumes of their portions.
Biochemical Analyses
We took peripheral blood samples before the procedure, and measured the plasma concentrations of TGF-β, TIMP-1, angiotensin converting enzyme (ACE), angiotensin II, and MMP-1, 2, and 9 by ELISA kits (R&D Systems, Minneapolis, MN, USA).
Data Analyses
We evaluated the degree of electroanatomical remodeling by the mean and regional LA voltage and the mean and regional LA volume. The degree of electroanatomical remodeling was compared with clinical parameters, and the plasma concentrations of multiple biological markers. Comparisons between groups were analyzed by the Mann -Whitney test or the t-test. All values were expressed as mean ± SD. All statistical analyses were performed using SPSS version 12.0 and a P-value of <0.05 was considered significant. Table 1 summarizes the comparisons of clinical and electroanatomical characteristics according to plasma concentrations of TGF-β in patients with AF. We divided patients into those with TGF-β ≥10.0 ng/ml and those with TGF-β <10.0 ng/ml, based on the median value rounded to zero decimal places and validated it by receiver operating characteristic (ROC) curve analysis. There was no significant difference in baseline characteristics between the 2 groups.
Results
High Plasma Concentration of TGF-β Associated
Patients with TGF-β ≥10.0 ng/ml had a lower mean LA Tables 1,2 .
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inhibitor (ACEI) or angiotensin-receptor blocker (ARB) was not different, the plasma concentration of angiotensin II was significantly higher in patients with high TGF-β than those with low TGF-β (P=0.0066, Table 1 ). AF recurrence rates after catheter ablation were 17.6% and 20.0% in patients with TGF-β ≥10.0 ng/ml and those <10.0 ng/ml, respectively (P= 0.3446) during follow-up for 21.5±3.2 months.
High Plasma Concentration of TIMP-1 Related to Low LA Voltage
For patients with high plasma concentrations of TIMP-1, LA voltage was generally lower than those with low TIMP-1 ( Figure) . Table 2 compares clinical findings, LA voltage, and LA volume of the patients with plasma concentrations of TIMP-1 ≥1.1 ng/ml and those with <1.1 ng/ml. For statistical analyses, we decided the cut-off as the median rounded to zero decimal places and validated it by ROC curve analysis. Except for older age of patients with high TIMP-1, other clinical parameters were not significantly different. In the group with TIMP-1 ≥1.1 ng/ml, the mean LA voltage was significantly lower than the group with <1.1 ng/ml (1.26±0.54 mV vs. 1.80±0.83 mV, P=0.0006), and this trend was consistent at the LA anterior wall, septum, LAA, venous atrium, and left lateral isthmus area ( Table 2) . However, LA volume was not significantly different according to the plasma concentration of TIMP-1. In contrast, the proportion of patients who were taking ACEI/ARB was not different, the plasma concentration of angiotensin II was significantly higher in high TIMP-1 group than in low TIMP-1 group (P=0.0211, Table 2 ). Plasma concentrations of MMP-1, 2, and 9 were not different depending on LA volume or LA voltage.
Low Ventricular Systolic Function and Electroanatomical
Remodeling of LA As shown in Figure, patients with low EF tended to have an enlarged LA. Patients with EF ≤58% had greater LA size measured by echocardiography (P=0.0420) and LA volume measured by 3D-spiral CT (128.2±47.9 ml vs. 107.2±37.9 ml, P=0.0002) than those with EF >58% (Table 3) . Regional volumes of the venous atrium, LAA, and anterior LA were consistently larger in patients with EF ≤58% than those with >58%. In contrast, however, mean LA voltage was higher in low EF group (1.78±0.87 mV) than in high EF group (1.34± 0.56 mV, P=0.0038). Plasma concentrations of TGF-β (P= 0.0002) and TIMP-1 (P<0.0001) were lower in patients with low EF group than in high EF group. However, plasma concentrations of MMP-1, 2, and 9 were not affected by ventricular systolic function ( Table 3 ). The plasma concentrations of TGF-β (13.5±8.5 ng/ml vs. 9.7±7.8 ng/ml, P=0.0020) and TIMP-1 (1.5±1.2 ng/ml vs. 1.2±0.7 ng/ml, P=0.0034) were higher in patients with LV diastolic dysfunction (E/E' ≥8) than those without it (E/E' <8). However, LA volume or LA voltage was not significantly different. The patients who were taking ACEI/ARB were older (P=0.0003), had lower EF (P=0.0258), greater size of LA (P=0.0001), and lower LA endocardial voltage (P=0.0016) compared with those without ACEI/ARB ( Table 4 ). The plasma concentration of angiotensin II was also lower in patients who were taking Tables 1-3 .
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ACEI/ARB than those without it (P=0.0300). Therefore, the patients with more remodeled atrium and lower LV function were taking ACEI/ARB.
Discussion
The current study documented that high plasma concentration of TGF-β indicates low LA endocardial voltage and enlarged LA volume, suggesting electroanatomical remodeling in patients with non-valvular AF. We also found high plasma concentrations of TIMP-1 is related to low LA voltage, and low EF is associated with greater LA volume. Pre-determination of electroanatomical remodeling by these non-invasive parameters might be useful for the understanding of pathophysiology in patients with AF. 16 We recently reported that electroanatomically remodeled LA is found with low LA voltage and conduction velocity and high LA volume, especially anterior LA volume. 16 Therefore, slow conduction velocity and large critical mass in electroanatomically remodeled atria perpetuate the maintenance of AF. 27 Electroanatomical remodeling of LA changes AF dynamics and the characteristics or distribution of complex fractionated atrial electrogram. 28 In this study, plasma concentration of TGF-β and EF were found to be related to the enlargement of LA volume. However, TGF-β might not be a sensitive predictor for the structural remodeling process in AF, because it was associated with enlargement of venous atrium or LAA those remodel at the later phase of LA remodeling. 16
Pathophysiology of Structural
Atrial Fibrosis Associated With Plasma Concentrations of TGF-β and TIMP-1
It has been known that low voltage area in 3D electroanatomical map is related to the fibrotic scar in cardiac magnetic resonance image. 29 We evaluated the association between regional LA voltage and the plasma concentrations of biomarkers in this study. The delicate balance between production and degradation of extracellular matrix is maintained by multiple biophysical and biomolecular signalings that control fibroblast growth and function. 30 Disruption of this balance results in overwhelming fibrosis and structural remodeling with electrical and mechanical dysfunction. TGF-β is central to signaling cascades implicated in the activation of myofibroblasts and the genesis of cardiac fibrosis, 11,25,31 and is associated with an inhomogeneous substrate for electrical propagation. 32 Plasma concentration of TGF-β was reported to be related to the recurrence of AF after maze operation 33 and electrical cardioversion. 10 MMP are involved in the degradation of interstitial architecture 13 and have been found to play a significant role in the development of myocardial remodeling. The balancing of MMP and its antagonist TIMP regulates extracellular matrix turnover. 12-14 Their imbalance, change of MMP type, or elevated turnover of these matrix proteins are associated with atrial extracellular matrix remodeling and atrial dilation in AF. 34 We found that high plasma concentrations of TGF-β or TIMP-1 were associated with low LA voltage. However, MMP-1, 2, and 9 did not indicate the degree of atrial structural remodeling. It might be due to the peripheral blood samples only partially reflecting the remote process in the atria.
Potential Upstream Therapies in Management of AF
In the process of atrial electroanatomical remodeling, neurohormonal factors and hemodynamic factor should be considered. Angiotensin II is one of the important profibrotic molecules. 22 Although 2 recent randomized trials failed to reproduce the benefits of angiotensin II receptor blocker for rhythm control in patients with AF, 35,36 angiotensin II inhibitors might prevent atrial electrical and structural remodeling 37 and recurrence of AF 38 directly or indirectly by improving LV systolic or diastolic functions. In our study, both impaired LV systolic and diastolic functions increased plasma concentrations of TGF-β and TIMP-1, and LA volume was greater in patients with low EF. However, the reason for high LA voltage in patients with low EF remains to be studied. Another potential upstream therapies are statin, 39 ω-3 poly-unsaturated fatty acid, 40 and Perfenidone, a TGF-β1 inhibitor. 41 It has been known that angiotensin II activates GTPase Rac1 and STAT 3, which are the targets of statin and important signaling molecules mediating atrial structural remodeling. 42 ACE activity increases cardiac collagen content by degrading AcSDKP (N-acetyl-Ser-Asp-Lys-Pro), an inhibitor of the phosphorylated TGF-β signaling molecules. 43 Alterations in PDFG or myofibroblast might be another potential targets for upstream therapy that reduces electroanatomical remodeling of AF. 44,45
Study Limitations
The patients included in this study were a highly selected group referred for AF catheter ablation, and the number of patients was also limited. In this study data, clinical recurrence rate of the patients with LA volume ≥110 ml was significantly higher than those with LA volume <110 ml (25.2% vs. 9.7%, P=0.0018). However, we failed to prove the relationships between TGF-β and TIMP-1; those reflecting atrial remodeling and clinical recurrence of AF. This might be due to a relatively small number of sample size and selection bias excluding the patients with LA size >55 mm. The peripheral blood samples might only partially reflect the remote process in the atria. Because we acquired LA voltage by point-bypoint contact mapping, the LA voltage map did not reflect a spatiotemporally homogeneous distribution of endocardial voltage. We analyzed 3D maps using 2 dimensional measurements.
Conclusion
High plasma concentration of TGF-β was related with a low mean LA voltage and enlarged LA volume. The mean LA voltage was lower in patients with high TIMP-1 than those with low TIMP-1. In addition, LA volume was significantly greater in patients with low EF than those with normal LV systolic function. Pre-determination of electroanatomical remodeling by those non-invasive parameters might be useful for clinical decisions on rhythm control strategies and the TGF-β Predicts Remodeling of AF understanding of pathophysiology in patients with AF.
